Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Mesenchymal stem cells (MSCs) represent a promising tool for new clinical concepts in supporting cellular therapy. Bone marrow (BM) was the first source reported to contain MSCs. However, for clinical use, BM may be detrimental due to the highly invasive donation procedure and the decline in MSC number and differentiation potential with increasing age. More recently, umbilical cord blood (UCB), attainable by a less invasive method, was introduced as an alternative source for MSCs. Another promising source is adipose tissue (AT). We compared MSCs derived from these sources regarding morphology, the success rate of isolating MSCs, colony frequency, expansion potential, multiple differentiation capacity, and immune phenotype. No significant differences concerning the morphology and immune phenotype of the MSCs derived from these sources were obvious. Differences could be observed concerning the success rate of isolating MSCs, which was 100% for BM and AT, but only 63% for UCB. The colony frequency was lowest in UCB, whereas it was highest in AT. However, UCB-MSCs could be cultured longest and showed the highest proliferation capacity, whereas BM-MSCs possessed the shortest culture period and the lowest proliferation capacity. Most strikingly, UCB-MSCs showed no adipogenic differentiation capacity, in contrast to BM- and AT-MSCs. Both UCB and AT are attractive alternatives to BM in isolating MSC: AT as it contains MSCs at the highest frequency and UCB as it seems to be expandable to higher numbers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As plating density can affect proliferation kinetics of MSCs [16, 23], cells from all tissue sources were grown for at least two passages under two seeding densities: 300 and 3000 cells/cm2.”
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Human Adipose Tissue Is a Source of Multipotent Stem Cells
Zuk, P. A., Zhu, M., Ashjian, P., De Ugarte, D. A., Huang, J. I., Mizuno, H., Alfonso, Z. C., Fraser, J. K., Benhaim, P., & Hedrick, M. H. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-02-0105 · Cited by 6,664
Caplan, A. I. (1991) · Journal of Orthopaedic Research · doi:10.1002/jor.1100090504 · Cited by 6,548
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734
Horwitz, E. M., Gordon, P. L., Koo, W. K. K., Marx, J. C., Neel, M. D., McNall, R. Y., Muul, L., & Hofmann, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132252399 · Cited by 1,650
Mesenchymal progenitor cells in human umbilical cord blood
Erices, A., Conget, P., & Minguell, J. J. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01986.x · Cited by 1,613
Isolation of multipotent mesenchymal stem cells from umbilical cord blood
Lee, O. K., Kuo, T. K., Chen, W.-M., Lee, K.-D., Hsieh, S.-L., & Chen, T.-H. (2004) · Blood · doi:10.1182/blood-2003-05-1670 · Cited by 1,360
Wagner, W., Wein, F., Seckinger, A., Frankhauser, M., Wirkner, U., Krause, U., Blake, J., Schwager, C., Eckstein, V., Ansorge, W., et al. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.07.003 · Cited by 1,259
Stenderup, K. (2003) · Bone · doi:10.1016/j.bone.2003.07.005 · Cited by 1,206
Kögler, G., Sensken, S., Airey, J. A., Trapp, T., Müschen, M., Feldhahn, N., Liedtke, S., Sorg, R. V., Fischer, J., Rosenbaum, C., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040440 · Cited by 1,029
Research works printed but not linked: 1
- 10.1210/endo.134.1.8275945 · doi:10.1210/endo.134.1.8275945 · Paper page
Cited by
Items 401–500 of 1,013
Noer, A., Boquest, A. C., & Collas, P. (2007) · BMC Cell Biology · doi:10.1186/1471-2121-8-18 · Cited by 112
“ASCs display an immunophenotype similar to bone marrow MSCs and express genes extending across the three germ layers, supporting a differentiation potential toward non-mesodermal lineages [3,8,9].”
BackgroundMultilineage differentiation potential of equine blood-derived fibroblast-like cells
Giovannini, S., Brehm, W., Mainil‐Varlet, P., & Nešić, D. (2007) · Differentiation · doi:10.1111/j.1432-0436.2007.00207.x · Cited by 129
“, 2006) and MSC isolated from human bone marrow, adipose tissue, and umbilical cord blood differed in their isolation success rate, proliferation, and differentiation capacities (Kern et al., 2006).”
BackgroundNajar, M., Raicevic, G., Boufker, H. I., Fayyad‐Kazan, H., Bruyn, C. D., Meuleman, N., Bron, D., Toungouz, M., & Lagneaux, L. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2010.0159 · Cited by 117
“Among these tissues, adult human adipose tissue (AT) 14 and Wharton’s jelly (WJ) of the umbilical cord 15 have been considered the best potential alternatives.”
Mesenchymal stem cell-mediated transfer of mitochondria: mechanisms and functional impact
Velarde, F., Ezquerra, S., Delbruyere, X., Caicedo, A., Hidalgo, Y., & Khoury, M. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04207-3 · Cited by 118
Alzheimer’s Disease: Mechanism and Approach to Cell Therapy
Amemori, T., Jendelova, P., Ruzicka, J., Urdzikova, L., & Sykova, E. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125961 · Cited by 102
“[295–297].”
Cerqueira, M. T., Pirraco, R. P., Santos, T. C., Rodrigues, D. B., Frias, A. M., Martins, A., Reis, R. L., & Marques, A. P. (2013) · Biomacromolecules · doi:10.1021/bm4011062 · Cited by 118
Methodologies in creating skin substitutes
Nicholas, M. N., Jeschke, M. G., & Amini-Nik, S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2252-8 · Cited by 104
“However, the isolation of UMSCs is difficult and UMSCs are restricted in their potency, showing minimal adipogenic differentiation capacity [139].”
Ongaro, A., Pellati, A., Bagheri, L., Fortini, C., Setti, S., & Mattei, M. D. (2014) · Bioelectromagnetics · doi:10.1002/bem.21862 · Cited by 113
“…et al., 2011] and that increase in cAMP, induced by A2A and A2B adenosine receptors, can regulate the expression of specific osteogenic target genes such as Runx2 and Osterix [Lo et al., 2012; Carroll et al., 2012; Carroll and Ravid, 2013], suggesting a role for these receptors during osteogenesis.”
BackgroundAging and Diabetes Impair the Neovascular Potential of Adipose-Derived Stromal Cells
El‐ftesi, S., Chang, E. I.-F., Longaker, M. T., & Gurtner, G. C. (2009) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e3181954d08 · Cited by 118
Schäfer, R., Kehlbach, R., Wiskirchen, J., Bantleon, R., Pintaske, J., Brehm, B. R., Gerber, A., Wolburg, H., Claussen, C. D., & Northoff, H. (2007) · Radiology · doi:10.1148/radiol.2442060599 · Cited by 110
Injectable angiogenic and osteogenic carrageenan nanocomposite hydrogel for bone tissue engineering
Yegappan, R., Selvaprithiviraj, V., Amirthalingam, S., Mohandas, A., Hwang, N. S.-Y., & Jayakumar, R. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.10.182 · Cited by 110
UC blood-derived mesenchymal stromal cells: an overview
Flynn, A. W., Barry, F., & O’Brien, T. (2007) · Cytotherapy · doi:10.1080/14653240701584578 · Cited by 115
Busser, H., Najar, M., Raicevic, G., Pieters, K., Pombo, R. V., Philippart, P., Meuleman, N., Bron, D., & Lagneaux, L. (2015) · Stem Cells and Development · doi:10.1089/scd.2015.0172 · Cited by 118
Gentile, P., Scioli, M. G., Bielli, A., Orlandi, A., & Cervelli, V. (2017) · Regenerative Medicine · doi:10.2217/rme-2017-0076 · Cited by 109
Liu, W., Liu, A., Li, X., Sun, Z., Sun, Z., Liu, Y., Wang, G., Huang, D., Xiong, H., Yu, S., et al. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.06.012 · Cited by 107
Isolation of human mesenchymal stromal cells is more efficient by red blood cell lysis
Horn, P., Bork, S., Diehlmann, A., Walenda, T., Eckstein, V., Ho, A., & Wagner, W. (2008) · Cytotherapy · doi:10.1080/14653240802398845 · Cited by 107
Large‐scale production of human mesenchymal stem cells for clinical applications
Jung, S., Panchalingam, K. M., Wuerth, R. D., Rosenberg, L. C., & Behie, L. A. (2012) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1006 · Cited by 118
Breast Reconstruction with Enhanced Stromal Vascular Fraction Fat Grafting: What Is the Best Method?
Gentile, P., Scioli, M. G., Orlandi, A., & Cervelli, V. (2015) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000000285 · Cited by 113
“The subjective evaluation was based on the personal score of each patient focused on the following parameters: (1) presence of asymmetry, deformity, irregularity, dyschromia, dysesthesia, paraesthesia, and pain; (2) results of the superoexternal quadrant, inferoexternal quadrant, superointernal quadrant, and inferoint…”
MethodKocan, B., Maziarz, A., Tabarkiewicz, J., Ochiya, T., & Banaś-Ząbczyk, A. (2017) · Stem Cells International · doi:10.1155/2017/1653254 · Cited by 108
“The yield of these cells is from ~40- [18] even up to 500-fold greater in fat depots, compared to bone marrow [28, 29].”
BackgroundInfluentialAdipose-derived stromal cell in regenerative medicine: A review
Qomi, R. T., & Sheykhhasan, M. (2017) · World Journal of Stem Cells · doi:10.4252/wjsc.v9.i8.107 · Cited by 112
N. Momin, E., Vela, G., A. Zaidi, H., & Quinones-Hinojosa, A. (2010) · Current Immunology Reviews · doi:10.2174/157339510791111718 · Cited by 103
“Notably, adipose-derived MSCs are similar to those isolated from bone marrow in terms of morphology, the success rate of isolating MSCs, expansion potential, differentiation capacity, and immunophenotype [137,138], suggesting that they may be an ideal alternative source of MSCs.”
BackgroundMesenchymal Stem Cell Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Dave, M., Mehta, K. D., Luther, J., Baruah, A., Dietz, A. B., & Faubion, W. A. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000543 · Cited by 117
“MSCs have been isolated from various tissues including the bone marrow, adipose tissue, and human umbilical cord.(29) Their properties include in vitro proliferation with plastic-adherent properties bearing fibroblast-like morphology, the expression of MSC markers,”
BackgroundImmune regulatory properties of multipotent mesenchymal stromal cells: Where do we stand?
Bassi, Ê. J., Aita, C. A. M., & CAMARA, N. O. S. (2011) · World Journal of Stem Cells · doi:10.4252/wjsc.v3.i1.1 · Cited by 114
Mesenchymal stem cell-based treatment for cartilage defects in osteoarthritis
Qi, Y., Feng, G., & Yan, W. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1376-z · Cited by 105
“MSCs from bone marrow and adipose tissue were readily isolated and expanded, and adipose tissue contained the highest frequency of MSCs [20].”
Lee, T.-L., Lai, T.-C., Lin, S., Lin, S., Chen, Y., Pu, C., Lee, I., Tsai, J., Lee, C., & Chen, Y. (2021) · Theranostics · doi:10.7150/thno.52677 · Cited by 105
Shang, Y., Guan, H., & Zhou, F. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.570179 · Cited by 112
“UC-MSCs have the ability of multidirectional differentiation and have potential to differentiate into bone, adipose, cartilage and other tissues (Kfoury and Scadden, 2015; Richardson et al., 2016; Liu et al., 2018; Zhang et al., 2018; Shen et al., 2019; Yea et al., 2020), thus they can be used to…”
BackgroundHolt, D. D. C., Wood, J. A., Granick, J. L., Walker, N. J., Clark, K. C., & Borjesson, D. L. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0537 · Cited by 117
“Similar to other species, equine MSCs can be derived from several sources, including adipose tissue (AT), bone marrow (BM), umbilical cord blood (CB), and umbilical cord tissue (CT) [4–8].”
Jeon, Y., Kim, J., Cho, J. H., Chung, H., & Chae, J. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25395 · Cited by 101
“Approximately 10 year later, MSCs were finally identified in human adult BM [Kopen et al., 1999; Pittenger et al., 1999].”
BackgroundCurrent Therapeutic Strategies for Stem Cell-Based Cartilage Regeneration
Nam, Y., Rim, Y. A., Lee, J. J., & Ju, J. H. (2018) · Stem Cells International · doi:10.1155/2018/8490489 · Cited by 116
Park, J. H., Hwang, I., Hwang, S. H., Han, H. J., & Ha, H. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.09.034 · Cited by 107
“Although hUCB-MSC have less adipogenic differentiation capacity compared to bone marrow-derived MSC [49], the long-term effect of hUCB-MSC engrafted in diabetic kidneys needs to be investigated.”
BackgroundRossignoli, F., Caselli, A., Grisendi, G., Piccinno, M. S., Burns, J. S., Murgia, A., Veronesi, E., Loschi, P., Masini, C., Conte, P., et al. (2013) · BioMed Research International · doi:10.1155/2013/901821 · Cited by 104
“As summarized in Table 3, BM-MSC and AT-MSC senescence has been reported from passages 7 and 8 [32], while UC-MSC grow longer in culture, until passage 16 [31].”
BackgroundIn vitro comparison of feline bone marrow-derived and adipose tissue-derived mesenchymal stem cells
Webb, T. L., Quimby, J. M., & DOW, S. W. (2012) · Journal of Feline Medicine and Surgery · doi:10.1177/1098612x11429224 · Cited by 112
Wu, X., Luo, Y., Chen, J., Pan, R., Xiang, B., Du, X., Xiang, L., Shao, J., & Xiang, C. C. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0390 · Cited by 107
Amniotic Fluid and Placental Membranes: Unexpected Sources of Highly Multipotent Cells
Murphy, S. V., & Atala, A. (2013) · Seminars in Reproductive Medicine · doi:10.1055/s-0032-1331799 · Cited by 103
“40,41 These properties make placental MSCs attractive as a potential clinical therapy for in fl ammatory diseases.”
BackgroundKaewkhaw, R., Scutt, A. M., & Haycock, J. W. (2011) · Glia · doi:10.1002/glia.21145 · Cited by 102
“…the basal expression of S100b, GFAP, and p75NGFR na€ıve MSCs are not entirely in agreement, with positive and negative expression— agreeing (Bertani et al., 2005; Dezawa et al., 2001; Jones et al., 2002; Tondreau et al., 2004) and disagreeing (Caddick, 2006; Kingham et al., 2007) with our findings.”
BackgroundMethodResultInfluentialSalomone, F., Barbagallo, I. A., Puzzo, L., Piazza, C., & Volti, G. L. (2013) · Stem Cell Research · doi:10.1016/j.scr.2013.07.003 · Cited by 119
Susceptibility of Human Mesenchymal Stem Cells to Tacrolimus, Mycophenolic Acid, and Rapamycin
Hoogduijn, M. J., Crop, M. J., Korevaar, S. S., Peeters, A. M. A., Eijken, M., Maat, L. P. W. M., Balk, A. H. M. M., Weimar, W., & Baan, C. C. (2008) · Transplantation · doi:10.1097/tp.0b013e31818aa536 · Cited by 102
“Although MSC from different tissues have similar properties, there are quantitative differences between MSC from different sources (4, 33).”
BackgroundAnastomotic leak in colorectal cancer patients: New insights and perspectives
Foppa, C., Ng, S. C., Montorsi, M., & Spinelli, A. (2020) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2020.02.027 · Cited by 110
The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation
Kim, E., Kim, N., & Cho, S. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.2 · Cited by 119
Cheng, Y., Wang, S. B., Liu, J. H., Jin, L., Liu, Y., Li, C. Y., Su, Y., Liu, Y. R., Sang, X., Wan, Q., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12865 · Cited by 108
Stem cells from adipose tissue
Witkowska-Zimny, M., & Walenko, K. (2011) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-011-0005-0 · Cited by 116
“Given that the percentage of MSCs in bone Vol. 16.”
BackgroundInfluentialProduction of Mesenchymal Stem Cells through Stem Cell Reprogramming
Dayem, A. A., Lee, S. B., Kim, K., Lim, K. M., Jeon, T.-I., Seok, J., & Cho, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081922 · Cited by 104
Markov, V., Kusumi, K., Tadesse, M. G., William, D. A., Hall, D. M., Lounev, V., Carlton, A., Leonard, J., Cohen, R. I., Rappaport, E. F., et al. (2007) · Stem Cells and Development · doi:10.1089/scd.2006.0660 · Cited by 98
“These results correlate with the greater chondrogenic capacity observed in BM compared to the UCB MSCs (Fig.”
InfluentialBMP-6 is more efficient in bone formation than BMP-2 when overexpressed in mesenchymal stem cells
Mizrahi, O., Sheyn, D., Tawackoli, W., Kallai, I., Oh, A., Su, S., Da, X., Zarrini, P., Cook‐Wiens, G., Gazit, D., et al. (2012) · Gene Therapy · doi:10.1038/gt.2012.45 · Cited by 109
Electrophysiological properties of human adipose tissue-derived stem cells
Bai, X., Ma, J., Pan, Z., Song, Y.-H., Freyberg, S., Yan, Y., Vykoukal, D., & Alt, E. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00089.2007 · Cited by 98
Umbilical cord blood transplantation: Pros, cons and beyond
Stanevsky, A., Goldstein, G., & Nagler, A. (2009) · Blood Reviews · doi:10.1016/j.blre.2009.02.001 · Cited by 107
Taylor, S. E., SMITH, R. K. W., & Clegg, P. (2007) · Equine Veterinary Journal · doi:10.2746/042516407x180868 · Cited by 126
Mesenchymal stem cell therapy for liver fibrosis/cirrhosis
Cao, Y., Ji, C., & Lu, L. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.119 · Cited by 99
“Combined administration of macrophages and BM-MSCs induce the infiltration of host neutrophils into the liver fibrotic area, which contribute to liver fibrosis resolution and promote regeneration (58).”
BackgroundInfluentialValencia, J., Blanco, B., Yáñez, R., Vázquez, M., Sánchez, C. H., Fernández-García, M., Serrano, C. R., Pescador, D. B., Blanco, J. F., Hernando-Rodríguez, M., et al. (2016) · Cytotherapy · doi:10.1016/j.jcyt.2016.07.006 · Cited by 103
“Studies comparing MSCs derived from different sources have been focused on their phenotype, transcription profiling and differentiation potential [25–31] but also on their immunomodulatory properties [28,30,32–35], with controversial results.”
BackgroundManufacturing and banking of mesenchymal stem cells
Thirumala, S., Goebel, W. S., & Woods, E. J. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.763925 · Cited by 95
“Similarly, SVMSC and AT-MSC displayed a high potential for adipogenic differentiation [31], whereas CB-MSC did not [25].”
BackgroundResultInfluentialEx Vivo Expanded Mesenchymal Stromal Cell Minimal Quality Requirements for Clinical Application
Torre, M. L., Lucarelli, E., Guidi, S., Ferrari, M., Alessandri, G., De Girolamo, L., Pessina, A., Ferrero, I., & (GISM), O. B. O. T. G. I. S. M. (2015) · Stem Cells and Development · doi:10.1089/scd.2014.0299 · Cited by 93
“…cells, if compared to BM-MSCs, have been found to be genetically and morphologically more stable in culture [21], to have a lower senescence ratio [22], a higher proliferative capacity [21], to be able to retain differentiation potential for a longer period in culture [21], to be a more efficient…”
Human Fibroblasts Share Immunosuppressive Properties with Bone Marrow Mesenchymal Stem Cells
Fleury‐Cappellesso, S., Puissant‐Lubrano, B., Apoil, P. A., Titeux, M., Winterton, P., Casteilla, L., Bourin, P., & Blancher, A. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9415-4 · Cited by 108
“We and others recently demonstrated that human adipose tissue-derived stem cells which are also of mesenchymal origin, display immunosuppressive properties similar to those of BM-MSCs [20–22].”
BackgroundAdult Human Adipose Tissue Contains Several Types of Multipotent Cells
Tallone, T., Realini, C. A., Böhmler, A., Kornfeld, C. G., Vassalli, G., Moccetti, T., Bardelli, S., & Soldati, G. (2011) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-011-9257-3 · Cited by 110
Espagnolle, N., Balguerie, A., Arnaud, E., Sensebé, L., & Varin, A. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.02.008 · Cited by 101
“Our work confirms that injection of MSCs during the inflammatory phase optimizes the efficiency of MSCs in the treatment of inflammatory pathologies (Kern et al., 2006).”
BackgroundImmunomodulation by Mesenchymal Stromal Cells and Their Clinical Applications
Rilo, H., Cagliani, J. A., Grande, D. A., Molmenti, E. P., & Miller, E. J. (2017) · Journal of Stem Cell and Regenerative Biology · doi:10.15436/2471-0598.17.022 · Cited by 102
“However, adipose tissue and the umbilical cord, represent major alternative sources to bone marrow due to the easy accessibility with minimal invasive methods[8,9].”
BackgroundEngineering skeletal muscle tissue – new perspectives in vitro and in vivo
Klumpp, D., Horch, R. E., Kneser, U., & Beier, J. P. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01183.x · Cited by 95
“Though BMSCs have been commonly used, adipose-derived stem cells constitute an interesting alternative because they are easily accessible and show higher proliferation rates than BMSCs [88–89].”
BackgroundCirculating osteogenic cells: Implications for injury, repair, and regeneration
Pignolo, R. J., & Kassem, M. S. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.370 · Cited by 102
Perivascular cells as mesenchymal stem cells
Feng, J., Mantesso, A., & Sharpe, P. T. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2010.517191 · Cited by 103
“Depending on their origins, MSCs may also vary in colony-forming efficiency and growth potential [44] and immuno-regulatory activities (inhibition of T-cell proliferation) [34].”
BackgroundChoi, S. A., Hwang, S.-K., Wang, K.-C., Cho, B.-K., Phi, J. H., Lee, J. Y., Jung, H., Lee, D. H., & Kim, S. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq147 · Cited by 97
Shi, R., Jin, Y., Cao, C., Han, S., Shao, X., Meng, L., Cheng, J., Zhang, M., Zheng, J., Xu, J., et al. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0412-2 · Cited by 93
González, P. L., Carvajal, C., Cuenca, J., Alcayaga-Miranda, F., Figueroa, F. E., Bartolucci, J., Salazar-Aravena, L., & Khoury, M. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0022 · Cited by 95
Park, Y., Ha, C., Rhim, J. H., & Lee, H.-J. (2017) · The American Journal of Sports Medicine · doi:10.1177/0363546517729152 · Cited by 100
“Erices et al(25) concluded that the adhesive cells in hUCB were MSCs, and since then many studies have reported the isolation, proliferation, and differentiation potential of hUCB-MSCs.(11,41,99,118) The hUCB-MSCs have exhibited a higher proliferation rate, have shown karyotype stability after prolonged expansion, and…”
BackgroundResponses of adipose-derived stem cells during hypoxia: enhanced skin-regenerative potential
Chung, H.-M., Won, C.-H., & Sung, J.-H. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903307362 · Cited by 96
“A comparative analysis of MSCs obtained from bone marrow and adipose tissue clearly demonstrated that ASCs are equivalent to BMSCs with regard to morphology, cell surface receptor profile, and differentiation capacity [37,38].”
BackgroundIn vitro endothelial potential of human UC blood-derived mesenchymal stem cells
Gang, E. J., Jeong, J. A., Han, S., Yan, Q., Jeon, C., & Kim, H. (2006) · Cytotherapy · doi:10.1080/14653240600735933 · Cited by 106
Hildebrandt, C., Büth, H., Cho, S., Impidjati, & Thielecke, H. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.01.007 · Cited by 95
Stem cell sources for vascular tissue engineering and regeneration
Bajpai, V. K., & Andreadis, S. T. (2012) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2011.0264 · Cited by 95
Zucconi, E., Vieira, N. M., Bueno, D. F., Secco, M., Jazedje, T., Ambrósio, C. E., Passos‐Bueno, M. R., Miglino, M. A., & Zatz, M. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0314 · Cited by 107
Clinical Protocols for the Isolation and Expansion of Mesenchymal Stromal Cells
Bieback, K., Schallmoser, K., ter, H. K. U., & Strunk, D. (2008) · Transfusion Medicine and Hemotherapy · doi:10.1159/000141567 · Cited by 105
Self-citationAdipose stem cells for intervertebral disc regeneration: current status and concepts for the future
Hoogendoorn, R. J. W., Lu, Z., Kroeze, R. J., Bank, R. A., Wuisman, P. I. J. M., & Helder, M. N. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00291.x · Cited by 95
“MSCs from bone marrow are reported to provide a more suitable cell source for osteogenic and chondrogenic differentiation compared to ASCs [55–57], although no significant differences in terms of the multi-lineage differentiation capacity between ASCs and BMMSCs were found in two other reports [58, 59].”
ResultKim, J. H., Park, D. J., Yun, J. C., Jung, M. H., Yeo, H. D., Kim, H., Kim, D. W., Yang, J. I., Lee, G., Jeong, S., et al. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00060.2011 · Cited by 97
Baer, P. C., Griesche, N., Luttmann, W., Schubert, R., Luttmann, A., & Geiger, H. (2009) · Cytotherapy · doi:10.3109/14653240903377045 · Cited by 97
Griffiths, S., Baraniak, P. R., Copland, I. B., Nerem, R. M., & McDevitt, T. C. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2013.05.020 · Cited by 101
Fujii, Y., Kawase‐Koga, Y., Hojo, H., Yano, F., Sato, M., Chung, U., Ohba, S., & Chikazu, D. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0783-7 · Cited by 94
“In addition, MSCs progressively lose their multipotency and proliferative potential with age or during long-term culture [20].”
Cell-Based Vascularization Strategies for Skin Tissue Engineering
Hendrickx, B., Vranckx, J. J., & Luttun, A. (2010) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2010.0315 · Cited by 101
“87,92,97 Combining human CB-BOEC and BM-or CB-MSC in a subcutaneously implanted matrigel plug in mice resulted in a functional human vessel network that was stabilized by MSC-derived perivascular cells, suggesting for the benefit of a combined BOEC-MSC approach.”
InfluentialImpact of source tissue and ex vivo expansion on the characterization of goat mesenchymal stem cells
Mohamad‐Fauzi, N., Ross, P. J., Maga, E. A., & Murray, J. D. (2015) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/2049-1891-6-1 · Cited by 93
Doi, H., Kitajima, Y., Luo, L., Yan, C., Tateishi, S., Ono, Y., Urata, Y., Goto, S., Mori, R., Masuzaki, H., et al. (2016) · Scientific Reports · doi:10.1038/srep18844 · Cited by 91
Jeong, J. H., Lee, J. H., Jin, E. S., Min, J. K., Jeon, S. R., & Choi, K. H. (2010) · Acta Neurochirurgica · doi:10.1007/s00701-010-0698-2 · Cited by 99
“Other studies reported extracellular annulus fibrosus matrix synthesis, and the restoration of water disc height after the transplant of MSCs into IVDs to stimulatehost cell function as a drug effect [9, 18].”
InfluentialHuman mesenchymal stem cells from adipose tissue: Differentiation into hepatic lineage
Taléns-Visconti, R., Bonora, A., Jover, R., Mirabet, V., Carbonell, F., Castell, J. V., & Gómez-Lechón, M. J. (2007) · Toxicology in Vitro · doi:10.1016/j.tiv.2006.08.009 · Cited by 93
Human adipose-derived mesenchymal stem cells: serial passaging, doubling time and cell senescence
Gruber, H., Somayaji, S., Riley, F., Hoelscher, G., Norton, H., Ingram, J., & Hanley, E. (2012) · Biotechnic & Histochemistry · doi:10.3109/10520295.2011.649785 · Cited by 93
“Kern et al. (2006) reported that adiposederived MSC showed lower senescence at passage 2 (5.6”
BackgroundInfluentialSecco, M., Moreira, Y. B., Zucconi, E., Vieira, N. M., Jazedje, T., Muotri, A. R., Okamoto, O. K., Verjovski‐Almeida, S., & Zatz, M. (2009) · Stem Cell Reviews and Reports · doi:10.1007/s12015-009-9098-5 · Cited by 97
“Other studies have demonstrated that MSC populations obtained from different sources might exhibit significant differences in global gene expression patterns that are likely related to their differentiation capacities [3, 31, 54, 55].”
Payne, N. L., Sun, G., McDonald, C., Layton, D., Moussa, L., Emerson-Webber, A., Véron, N., Siatskas, C., Herszfeld, D., Price, J. T., et al. (2013) · Cell Transplantation · doi:10.3727/096368912x657620 · Cited by 97
Therapeutic Mesenchymal Stromal Cells for Immunotherapy and for Gene and Drug Delivery
Almeida-Porada, G. D., Atala, A., & Porada, C. D. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.01.005 · Cited by 97
Mechano-Bactericidal Titanium Surfaces for Bone Tissue Engineering
Clainche, T. L., Linklater, D. P., Wong, S., Le, P. H., Juodkazis, S., Guével, X. L., Coll, J., Ivanova, E. P., & Martel‐Frachet, V. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c11502 · Cited by 93
Abreu, S. C., Lopes-Pacheco, M., Weiss, D. J., & Rocco, P. R. M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.600711 · Cited by 86
“These vesicles are characterized by exposing phosphatidylserine to the extracellular compartment Frontiers in Cell and Developmental Biology | www.frontiersin.org 3 February 2021 | Volume 9 | Article 600711 and containing histones and fragmented DNA (Kerr et al., 1972; Atkin-Smith et al., 2015; O’Farrell and Yang, 201…”
BackgroundInfluentialManufacturing artificial bone allografts: a perspective.
Steijvers, E., Ghei, A., & Xia, Z. (2022) · PubMed Central · doi:10.12336/biomatertransl.2022.01.007 · Cited by 116
“77 Umbilical cord blood MSCs were shown to have the highest expansion potential, allowing subculture for at least 10 passages, while adipose tissue MSCs showed much lower senescence in earlier passages.”
InfluentialMartinello, T., Bronzini, I., Maccatrozzo, L., Iacopetti, I., Sampaolesi, M., Mascarello, F., & Patruno, M. (2009) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2009.0512 · Cited by 103
“8,9 Further, these cells possess the peculiar ability to differentiate along several cell lineages, including chondrocytes, 10 adipocytes, and myoblasts.”
Bearden, R. N., Huggins, S. S., Cummings, K. J., Smith, R., Gregory, C. A., & Saunders, W. B. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0639-6 · Cited by 91
Mesenchymal Stem Cell Assays and Applications
Vemuri, M. C., Chase, L. G., & Rao, M. S. (2011) · Methods in molecular biology · doi:10.1007/978-1-60761-999-4_1 · Cited by 91
Epigenetic programming of mesenchymal stem cells from human adipose tissue
Boquest, A. C., Noer, A., & Collas, P. (2006) · Stem Cell Reviews and Reports · doi:10.1007/bf02698059 · Cited by 102
Homing endonucleases: from basics to therapeutic applications
Marcaida, M. J., Muñoz, I. G., Blanco, F. J., Prìeto, J., & Montoya, G. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0188-y · Cited by 102
In vitro clinical‐grade generation of red blood cells from human umbilical cord blood CD34+ cells
Baek, E. J., Kim, H., Kim, S., Jin, H., Choi, T. Y., & Kim, H. O. (2008) · Transfusion · doi:10.1111/j.1537-2995.2008.01828.x · Cited by 91
Mesenchymal Stem Cells: New Approaches for the Treatment of Neurological Diseases
Momin, E. N., Mohyeldin, A., Zaidi, H. A., Vela, G., & Quiñones‐Hinojosa, A. (2010) · Current Stem Cell Research & Therapy · doi:10.2174/157488810793351631 · Cited by 99
“This technique reliably yields cells with an immunophenotype consistent with the ISCT definition for MSCs, and capable of differentiating into the 3 mesenchymal lineages [36].”
BackgroundMethodResultInfluentialNishino, Y., Yamada, Y., Ebisawa, K., Nakamura, S., Okabe, K., Umemura, E., Hara, K., & Ueda, M. (2011) · Cytotherapy · doi:10.3109/14653249.2010.542462 · Cited by 98
YIN, L., ZHU, Y., YANG, J., NI, Y., ZHOU, Z., CHEN, Y., & WEN, L. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2935 · Cited by 88
“Adipose tissue contains stem cells similar to BMSCs; these cells could be isolated from cosmetic liposuctions and grown easily under standard tissue culture conditions (3).”
BackgroundKoch, T. G., Heerkens, T. M.-J., Besonov, K., Thomsen, P. D., Betts, D. H., & Berg, L. C. (2009) · Veterinary and Comparative Orthopaedics and Traumatology · doi:10.3415/vcot-08-10-0107 · Cited by 103
“Studies on human cord blood derived MSC suggest that these cells have higher replicative potential and broader potency, as illustrated by their longer telomeres, compared to bone marrow derived cells, and the ability to become tissues of endoderm and ectoderm origin in addition to the common mesoderm cell lineages (17…”
BackgroundBurrow, K. L., Hoyland, J. A., & Richardson, S. M. (2017) · Stem Cells International · doi:10.1155/2017/2541275 · Cited by 87
Adipose-Derived Mesenchymal Stromal Cells in Basic Research and Clinical Applications
Czerwiec, K., Zawrzykraj, M., Deptuła, M., Skoniecka, A., Tymińska, A., Zieliński, J., Kosiński, A., & Pikuła, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043888 · Cited by 80
“In terms of similarities, AD-MSC and BM-MSC show the same amount of expression for CD13 (alanyl aminopeptidase, membrane), CD29 (integrin subunit beta), CD73 (5′-nucleotidase ecto), CD90 (Thy-1 cell surface antigen), CD105 (endoglin), and HLA-DR (major histocompatibility complex) [40,42].”
BackgroundAdipose Tissue-Derived Mesenchymal Stem Cells: Isolation, Expansion, and Characterization
Araña, M., Mazo, M. M., Aranda, P., Pelacho, B., & Prósper, F. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-511-8_4 · Cited by 96
Castro-Manrreza, M. E., Mayani, H., Monroy-García, A., Flores-Figueroa, E., Chávez-Rueda, K., Legorreta-Haquet, V., Santiago-Osorio, E., & Montesinos, J. J. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0363 · Cited by 85
“MSCs from the three sources met the criteria established by the ISCT [29] with regard to immunophenotype, osteogenic, and chondrogenic differentiation capacities; however, as we have previously demonstrated [18], UCB-MSCs showed no adipogenic capacity, unlike BM-MSCs and PLMSCs, a fact that has been corroborated by ot…”
Schäfer, R., Kehlbach, R., Müller, M., Bantleon, R., Kluba, T., Ayturan, M., Siegel, G., Wolburg, H., Northoff, H., Dietz, K., et al. (2009) · Cytotherapy · doi:10.1080/14653240802666043 · Cited by 89
Metadata
- Authors
- Kern, S., Eichler, H., Stoeve, J., Klüter, H., & Bieback, K.
- Affiliations
- German Red Cross (DE)
- Department of Orthopaedic Surgery of the University Hospital Mannheim, University of Heidelberg, Faculty of Clinical Medicine, Mannheim, Germany
- Corresponding author
- Bieback, Karen
- Venue
- STEM CELLS
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-05
- Volume
- 24
- Issue
- 5
- Pages
- 1294-1301
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W2036348189
- Cited by
- 3,370
- References
- 37
- Citations by year
- 2026: 57 · 2025: 97 · 2024: 142 · 2023: 136 · 2022: 176 · 2021: 201 · 2020: 225 · 2019: 197 · 2018: 190 · 2017: 193 · 2016: 208 · 2015: 218 · 2014: 225 · 2013: 242 · 2012: 213
- FWCI
- 49.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- onlinelibrary.wiley.com/termsAndConditions#vor (vor)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Locations
- Stem Cells (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- mesenchymal stem cells, bone marrow, umbilical cord blood, adipose tissue, stem cell isolation, adipogenesis, multilineage differentiation, immunophenotype, stem cell expansion, cell therapy
- MeSH terms
- Adipose Tissue, Aged, Aged, 80 and over, Antigens, Surface, Bone Marrow Cells, Cell Differentiation, Cells, Cultured, Fetal Blood, Humans, Osteogenesis, Immunophenotyping, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.